in k€ | 01/01 – 03/31/2019 | 01/01 – 03/31/2018 | Change in % |
|---|---|---|---|
Sales | 16,457 | 16,758 | -1.8 % |
Gross profit | 5,716 | 5,907 | -3.2 % |
Gross margin | 34.7 % | 35.2 % | – |
EBITDA | 778 | 973 | -20.0 % |
EBITDA margin | 4.7 % | 5.8 % | – |
EBITDA underlying | 1,553 | 1,818 | -14.6 % |
EBITDA margin underlying | 9.4 % | 10.8 % | – |
EBIT | -19 | 705 | n.a. |
EBIT margin | -0.1 % | 4.2 % | – |
EBIT underlying | 756 | 1,550 | -51.2 % |
EBIT margin underlying | 4.6 % | 9.2 % | – |
Consolidated net loss of period | -320 | 326 | n.a. |
Net loss per share, not diluted | -0.03 | 0.03 | n.a. |
Net loss per share, diluted | -0.03 | 0.03 | n.a. |
in k€ | 03/31/2019 | 03/31/2018 | Change in % |
|---|---|---|---|
Order backlog | 13,653 | 16,914 | -19.3 % |
in k€ | 03/31/2019 | 12/31/2018 | Change in % |
|---|---|---|---|
Equity | 18,068 | 18,204 | -0.7 % |
Equity ratio | 35.4 % | 43.3 % | – |
Balance sheet total | 50,991 | 42,065 | 21.2 % |
Cash (freely available) | 4,512 | 7,520 | -40.0 % |
03/31/2019 | 03/31/2018 | Change in % | |
|---|---|---|---|
Permanent employees | 280 | 263 | 6.5 % |
Effect of IFRS 16 on earnings figure | |
|---|---|
EBITDA (underlying) | 560 |
EBIT (underlying) | 37 |
Consolidated net results | -25 |